Patent · US Active

Compositions for treating multiple sclerosis

US9517253B2 · kind B2 · utility

0Cited by
1References
9Claims
0Family size

Assignee

Inventor

Key dates

Filing dateOct 17, 2008
Grant dateDec 13, 2016
Priority date—
Expiry dateFeb 16, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2239/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions comprising Tr1 cells directed to a multiple sclerosis associated antigen and methods for treating multiple sclerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.